Castle Biosciences director gifts 5,985 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Castle Biosciences director Daniel Bradbury reported a 5,985-share bona fide gift for no consideration on November 17, 2026, to a charitable donor advised fund. Bradbury retained no voting, investment, or pecuniary interest in the gifted shares. The reported post-transaction position was 29,646 shares held by The Bradbury Family Trust; a footnote says this reflects a transfer of 22,340 shares from direct holdings to the trust.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock F1, F2, F3 | 5,985 | $0.00 | $0.00 |
Footnotes (3)
- F1. Represents a bona fide gift by the Reporting Person, for no consideration, to a charitable donor advised fund. The Reporting Person retains no voting, investment, or pecuniary interest in the gifted shares.
- F2. Reflects the November 17, 2026 transfer of 22,340 shares from their direct holdings to The Bradbury Family Trust.
- F3. Held by Bradbury Family Trust of which the Reporting Person and Annette Bradbury are the trustees and the beneficiaries.
Key Figures
Key Terms
donor advised fund financial
pecuniary interest regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who are the trustees and beneficiaries of CSTL director Daniel Bradbury's family trust?
AI-generated analysis. How Rhea-AI works. Not financial advice.